Which topical antibiotic is appropriate for treating a Proteus mirabilis inframammary skin infection?

Topical Antibiotic Treatment for Proteus mirabilis Inframammary Infection

Topical antibiotics are NOT appropriate for treating Proteus mirabilis skin infections—systemic antibiotics are required for this pathogen.

Why Topical Therapy is Inadequate

Proteus mirabilis is fundamentally different from the typical skin pathogens (Staphylococcus aureus and Streptococcus species) that respond to topical antibiotics. The IDSA guidelines 1 specifically address topical therapy for impetigo and superficial skin infections caused by staphylococci and streptococci, recommending mupirocin or retapamulin for these organisms. However, P. mirabilis is a gram-negative rod that is not covered by standard topical antibiotics used in dermatology.

The evidence confirms this distinction:

• Mupirocin, the most commonly recommended topical agent 1, 2, has activity against staphylococci, streptococci, H. influenzae, and N. gonorrhoeae—but not Proteus species 2
• Standard topical antibiotics (erythromycin, clindamycin, mupirocin, fusidic acid) target gram-positive organisms 3

Required Treatment Approach

You must use systemic antibiotics based on culture and susceptibility testing. Here's the algorithmic approach:

Step 1: Obtain Cultures

• Swab or aspirate the infected area for culture and sensitivity
• P. mirabilis frequently demonstrates multidrug resistance 4, 5

Step 2: Empiric Systemic Therapy (while awaiting cultures)

For suspected P. mirabilis infection, consider:

• Fluoroquinolones (ciprofloxacin or levofloxacin)
• Third-generation cephalosporins (ceftriaxone or ceftazidime)
• Avoid empiric beta-lactams if resistance is suspected 4

Step 3: Adjust Based on Susceptibility

• Tailor antibiotics to antibiogram results
• Be aware of carbapenemase genes (bla-VIM, bla-OXA variants) that confer resistance 6

Critical Pitfalls to Avoid

⚠️ Do not use topical therapy alone—P. mirabilis causes deeper tissue infections that require systemic penetration 4

⚠️ Do not assume beta-lactam susceptibility—resistance is increasingly common 5, 6

⚠️ Do not use corticosteroids empirically—they can worsen bacterial infections and promote progression 4

⚠️ Repeat cultures if clinical deterioration occurs despite treatment—mixed infections with MRSA can complicate P. mirabilis cases 4

Local Wound Care Adjuncts

While systemic antibiotics are treating the infection:

• Keep the area clean and dry
• Cover with sterile dressing
• Consider incision and drainage if abscess formation occurs 1